A Day Up For ChemoCentryx, Inc.
Fri, Oct 08, 2021 at 05:33 PM
ChemoCentryx, Inc. (CCXI:NASDAQ) jumped higher at $38.41, a gain of 96%. On Thu, Oct 07, 2021, CCXI:NASDAQ hit a New 2-Week Intraday High of $21.31. The stock got featured on our News Catalysts scanner on Fri, Oct 08, 2021 at 02:41 PM in the 'BIOTECH' category. From Thu, Sep 23, 2021, the stock recorded 70.00% Up Days and 72.73% Green Days
About ChemoCentryx, Inc. (CCXI:NASDAQ)
ChemoCentryx Inc is a biopharmaceutical company. It is engaged in discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer.
Top 10 Gainers:
- ChemoCentryx, Inc. (CCXI:NASDAQ), 95.97%
- DATS (DATS:NASDAQ), 45.77%
- Voyager Therapeutics, Inc. (VYGR:NASDAQ), 44.53%
- Renren Inc. (RENN:NYSE), 44.46%
- HUDI (HUDI:NASDAQ), 36.27%
- ORIC Pharmaceuticals, Inc. (ORIC:NASDAQ), 25.9%
- NXTP (NXTP:NASDAQ), 23.68%
- MITC (MITC:NASDAQ), 21.98%
- Altisource Portfolio Solutions S.A. (ASPS:NASDAQ), 21.19%
- Aehr Test Systems (AEHR:NASDAQ), 16.69%